Treating generalised anxiety disorder
- Alison Tonks (atonks@bmj.com), freelance medical editor
- BMJ Unified, London WC1H 9JR
- Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand
- BMJ Unified, London WC1H 9JR
Description Generalised anxiety disorder is a chronic, disabling mental illness affecting 1-2% of adults.1 It is characterised by worry and anxiety that are hard to control and that interfere with daily functioning. Although common and treatable, it remains underdiagnosed and undertreated.2 Only half of people with the disorder consult a doctor for it. Those who do are rarely offered the most effective treatment—cognitive therapy. Most patients are seen and treated by primary care doctors, who may be unfamiliar with the condition. About 8% of patients consulting primary care professionals have generalised anxiety disorder.3 Treatment involves cognitive therapy or medication. There are large gaps in the evidence on treatments, such as on their long term effects or on the value of combining cognitive therapy with medication.
Research Several factors complicate research into treatment of generalised anxiety disorder:
Drug trials have high dropout rates, partly because of side effects4
The disorder has a relapsing and remitting course; improvements are not always due to treatment
The placebo effect is powerful—trials have to be large to show a treatment effect5
Most treatments take several weeks or even months to work2
The definition of generalised anxiety disorder has changed four times since 1980.6
Prognosis Complete recovery is rare. Explain to your patients that you are aiming for remission rather than cure. A reasonable goal is to reduce symptoms by about 50% and improve quality of life.7 Patients shouldn't expect any benefit until eight to 12 weeks after starting treatment.2
Treatment
These articles, and the patients' version, will help you and your patients discuss treatment options together and choose treatments that are supported by evidence from randomised controlled trials. Clear, concise information is important for people with generalised anxiety disorder, who may have difficulty concentrating or making …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record







CiteULike
Connotea
Del.icio.us
Digg
Facebook
Mendeley
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: Transforming translation
Published 30 May 2012
Re: Bringing Nightingale down to size
Published 29 May 2012
Re: Avoid antimuscarinic drugs in people with dementia
Published 29 May 2012
Re: Strengthening primary health care: Related to the integration of medical training, community service need and health administration
Published 29 May 2012
Re: Strengthening primary health care: Related to the integration of medical training, community service need and health administration
Published 29 May 2012
Most responses
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10 (12 responses)
Published 10 May 2012 - 23:32
The psychiatric oligarchs who medicalise normality (9 responses)
Published 2 May 2012 - 15:42
Are doctors justified in taking industrial action in defence of their pensions? No (8 responses)
Published 8 May 2012 - 12:21
Are doctors justified in taking industrial action in defence of their pensions? Yes (8 responses)
Published 8 May 2012 - 12:21
The hardest thing: admitting error (7 responses)
Published 2 May 2012 - 12:27